Developer docs
API playgroundTry for free, no card

Search company profiles

Oscor

Full company profile

uuid000bbtp

Namestring
Oscor
Legal namestring
Oscor
Company typeenum
Private
Founded yearint
1982
Descriptiontext

Oscor is a privately held medical device manufacturer founded in 1982 and headquartered in Palm Harbor, Florida, operating with 501-1000 employees. The company designs and manufactures diagnostic devices, medical supplies, and healthcare equipment, with its primary disclosed product line being catheter introducer kits used with Impella heart pumps for cardiac procedures. Oscor's central commercial relationship is as a contract manufacturing partner to J&J's Abiomed unit, producing catheter introducer kits for the cardiovascular sector under an OEM/licensing arrangement.

The company's business model centers on medical device contract manufacturing rather than branded end-product sales; Oscor does not appear to own a consumer-facing brand or distribution channel, and revenue mechanics are tied to OEM production volumes and quality-of-supply contracts. Its customer base, as evidenced in the input, is highly concentrated around a single tier-1 cardiovascular OEM relationship. The founder, Peter Osypka, remains as founder, president, and CEO, indicating founder-led continuity through the company's 44-year history.

Operationally, Oscor faces an acute regulatory event: in April 2026 the FDA issued an early alert to Abiomed and Oscor regarding catheter introducer kits, citing manufacturing issues that could cause sheath leakage and have been linked to eight reported major bleeding events and three patient deaths. The company and its partner issued customer notifications recommending device corrections. No pricing model, geographic market footprint, or AI/technology differentiation is disclosed in the available sources.

Short descriptiontext

Oscor is a privately held, Palm Harbor, Florida-based medical device manufacturer founded in 1982 that produces catheter introducer kits and related cardiovascular devices, primarily as a contract manufacturing partner for J&J's Abiomed unit.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersPalm Harbor, United States
HQ citystring
Palm Harbor
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
cardiac medical devices, catheter introducer kits, medical device manufacturing, cardiovascular medical supplies, diagnostic medical devices
Industry3 codes
1Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation)
CodeHLAHAFALPrimaryYes
2Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts)
CodeHLAHAFAHPrimaryNo
3Mechanical Circulatory Support (VAD, IABP, ECMO)
CodeHLAHAFAGPrimaryNo
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Cardiovascular Medical Device Manufacturing
Social media profiles2 records
Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Oscor manufactures and supplies diagnostic devices, medical supplies, and healthcare equipment, with a focus on cardiovascular medical device components. The company operates as an OEM contract manufacturer, producing catheter introducer kits used with Impella heart pumps for cardiac procedures on behalf of partners such as J&J's Abiomed unit.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Oscor is a manufacturing partner for Johnson & Johnson's Abiomed unit, producing catheter introducer kits specifically designed for use with Impella heart pumps. The company operates as a medical device contract manufacturer in the cardiovascular space.

Partnership1 partner
1J&J's Abiomed unit
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Oscor serves as a manufacturing partner to J&J's Abiomed unit, producing catheter introducer kits used with Impella heart pumps. The partnership involves manufacturing medical devices for the cardiovascular sector. The FDA has issued an early alert regarding these catheter introducer kits, citing manufacturing issues that could cause sheath leakage and increase the risk of access-site bleeding.

fiercebiotech.com
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeBroad incumbent
Description

Boston Scientific has deep exposure to interventional cardiology and structural heart devices, including heart failure therapies — comparable to Oscor's positioning within the supply chain of major cardiovascular OEMs.

TypeDirect peer
Description

ICU Medical manufactures medical connectors, catheters, and custom medical devices for OEM customers, with comparable contract-manufacturing capabilities and customer base overlap with Oscor's OEM-focused cardiovascular manufacturing.

TypeDirect peer
Description

Integer is a leading medical device outsourcing manufacturer producing catheters, introducers, Class III devices, and other components across 15+ cardiovascular and neuromodulation markets — directly comparable to Oscor's role as an OEM contract manufacturer of catheter introducer kits and cardiovascular components.

TypeEmerging player
Description

Nipro manufactures and supplies catheters, introducers, and related vascular access devices as an OEM manufacturer with significant overlap in introducer and cardiovascular component manufacturing.

TypeDirect peer
Description

Creganna, part of TE Connectivity, designs and manufactures minimally invasive delivery and access devices including catheters and introducers for cardiovascular OEMs — closely comparable to Oscor's contract manufacturing role.

TypeDirect peer
Description

Teleflex manufactures and supplies a broad portfolio of catheter introducers and vascular access devices, overlapping directly with Oscor's catheter introducer kit product line and cardiovascular OEM supply positioning.

TypeBroad incumbent
Description

Abiomed (J&J MedTech) is Oscor's core OEM customer and the manufacturer of Impella heart pumps; it operates broadly across interventional cardiology and mechanical circulatory support and is comparable as the end-OEM for whom Oscor manufactures components.

TypeBroad incumbent
Description

Edwards is a global leader in structural heart and critical care monitoring, representing a broader incumbent in the same cardiovascular device category where Oscor operates as a component manufacturer.

TypeBroad incumbent
Description

Medtronic is the largest broad incumbent in cardiac and vascular devices, including mechanical circulatory support and heart failure therapy — comparable to Oscor's served cardiovascular end markets.

TypeBroad incumbent
Description

Abbott operates one of the largest cardiovascular device portfolios including mechanical circulatory support and structural heart products, making it a comparable broad incumbent in the same end markets Oscor supplies into.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Oscor

Cardiovascular Medical Device Manufacturingoscor.com

Oscor is a privately held, Palm Harbor, Florida-based medical device manufacturer founded in 1982 that produces catheter introducer kits and related cardiovascular devices, primarily as a contract manufacturing partner for J&J's Abiomed unit.

What Oscor does

Oscor is a privately held medical device manufacturer founded in 1982 and headquartered in Palm Harbor, Florida, operating with 501-1000 employees. The company designs and manufactures diagnostic devices, medical supplies, and healthcare equipment, with its primary disclosed product line being catheter introducer kits used with Impella heart pumps for cardiac procedures. Oscor's central commercial relationship is as a contract manufacturing partner to J&J's Abiomed unit, producing catheter introducer kits for the cardiovascular sector under an OEM/licensing arrangement.

The company's business model centers on medical device contract manufacturing rather than branded end-product sales; Oscor does not appear to own a consumer-facing brand or distribution channel, and revenue mechanics are tied to OEM production volumes and quality-of-supply contracts. Its customer base, as evidenced in the input, is highly concentrated around a single tier-1 cardiovascular OEM relationship. The founder, Peter Osypka, remains as founder, president, and CEO, indicating founder-led continuity through the company's 44-year history.

Operationally, Oscor faces an acute regulatory event: in April 2026 the FDA issued an early alert to Abiomed and Oscor regarding catheter introducer kits, citing manufacturing issues that could cause sheath leakage and have been linked to eight reported major bleeding events and three patient deaths. The company and its partner issued customer notifications recommending device corrections. No pricing model, geographic market footprint, or AI/technology differentiation is disclosed in the available sources.

Oscor firmographics

Firmographics
Name
Oscor
Legal name
Oscor
Website
http://oscor.com
Company type
Private
Founded year
1982
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Oscor is a privately held, Palm Harbor, Florida-based medical device manufacturer founded in 1982 that produces catheter introducer kits and related cardiovascular devices, primarily as a contract manufacturing partner for J&J's Abiomed unit.
Ownership category
akta.pro rank

Oscor industry classification

Industry
Product category
Cardiovascular Medical Device Manufacturing
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)
akta.pro secondary industries
Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH), Mechanical Circulatory Support (VAD, IABP, ECMO) (HLAHAFAG)

Keywords

  • Cardiac medical devices
  • Catheter introducer kits
  • Medical device manufacturing
  • Cardiovascular medical supplies
  • Diagnostic medical devices

Where Oscor is headquartered

Location

Headquarters

HQ city
Palm Harbor
HQ country
United States
HQ region
North America

Markets served

Oscor business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Oscor product offering

Product offering

Core offering

Oscor manufactures and supplies diagnostic devices, medical supplies, and healthcare equipment, with a focus on cardiovascular medical device components. The company operates as an OEM contract manufacturer, producing catheter introducer kits used with Impella heart pumps for cardiac procedures on behalf of partners such as J&J's Abiomed unit.

Product overview

Oscor is a manufacturing partner for Johnson & Johnson's Abiomed unit, producing catheter introducer kits specifically designed for use with Impella heart pumps. The company operates as a medical device contract manufacturer in the cardiovascular space.

Differentiator

Problem solved

Functional benefit

Companies that use Oscor

Customer profile

Ideal customer profiles1 record

Oscor technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Oscor partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • J&J's Abiomed unitcoreOEM/ Whitelabel/ Licensing PartnerOscor serves as a manufacturing partner to J&J's Abiomed unit, producing catheter introducer kits used with Impella heart pumps. The partnership involves manufacturing medical devices for the cardiovascular sector. The FDA has issued an early alert regarding these catheter introducer kits, citing manufacturing issues that could cause sheath leakage and increase the risk of access-site bleeding.

Recent moves3 records

Oscor competitors and assessment

Company assessment

Broad incumbents

  • Boston Scientific: Boston Scientific has deep exposure to interventional cardiology and structural heart devices, including heart failure therapies — comparable to Oscor's positioning within the supply chain of major cardiovascular OEMs.
  • J&J MedTech (Abiomed): Abiomed (J&J MedTech) is Oscor's core OEM customer and the manufacturer of Impella heart pumps; it operates broadly across interventional cardiology and mechanical circulatory support and is comparable as the end-OEM for whom Oscor manufactures components.
  • Edwards Lifesciences: Edwards is a global leader in structural heart and critical care monitoring, representing a broader incumbent in the same cardiovascular device category where Oscor operates as a component manufacturer.
  • Medtronic: Medtronic is the largest broad incumbent in cardiac and vascular devices, including mechanical circulatory support and heart failure therapy — comparable to Oscor's served cardiovascular end markets.
  • Abbott: Abbott operates one of the largest cardiovascular device portfolios including mechanical circulatory support and structural heart products, making it a comparable broad incumbent in the same end markets Oscor supplies into.

Direct peers

  • ICU Medical: ICU Medical manufactures medical connectors, catheters, and custom medical devices for OEM customers, with comparable contract-manufacturing capabilities and customer base overlap with Oscor's OEM-focused cardiovascular manufacturing.
  • Integer Holdings: Integer is a leading medical device outsourcing manufacturer producing catheters, introducers, Class III devices, and other components across 15+ cardiovascular and neuromodulation markets — directly comparable to Oscor's role as an OEM contract manufacturer of catheter introducer kits and cardiovascular components.
  • Creganna Medical (TE Connectivity): Creganna, part of TE Connectivity, designs and manufactures minimally invasive delivery and access devices including catheters and introducers for cardiovascular OEMs — closely comparable to Oscor's contract manufacturing role.
  • Teleflex: Teleflex manufactures and supplies a broad portfolio of catheter introducers and vascular access devices, overlapping directly with Oscor's catheter introducer kit product line and cardiovascular OEM supply positioning.

Emerging players

  • Nipro Medical: Nipro manufactures and supplies catheters, introducers, and related vascular access devices as an OEM manufacturer with significant overlap in introducer and cardiovascular component manufacturing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Oscor social profiles

Digital presence

Oscor financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Oscor leadership team

Management profile

Number of profiles

Profiles1 record

Oscor funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Oscor M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oscor

What does Oscor do?

Oscor manufactures and supplies diagnostic devices, medical supplies, and healthcare equipment, with a focus on cardiovascular medical device components. The company operates as an OEM contract manufacturer, producing catheter introducer kits used with Impella heart pumps for cardiac procedures on behalf of partners such as J&J's Abiomed unit.

Is Oscor a public or private company?

Oscor is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Oscor founded?

Oscor was founded in 1982. It employs 501 to 1,000 people.

Where is Oscor based?

Oscor is headquartered in Palm Harbor, United States, in the North America region.

Who are Oscor's main competitors?

Broad incumbents on record are Boston Scientific, J&J MedTech (Abiomed), Edwards Lifesciences, Medtronic and Abbott. Direct peers are ICU Medical, Integer Holdings, Creganna Medical (TE Connectivity) and Teleflex. Nipro Medical is listed as an emerging player.

Does Oscor have an API?

No public API is recorded for Oscor.

What industry is Oscor in?

Oscor's product category is Cardiovascular Medical Device Manufacturing. Its primary akta.pro industry code is HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation), with a secondary code of HLAHAFAH, Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comMedical Device Outsourcing Market Current Scenario with Future Aspect AnalysisInsightAce Analytic released a market assessment report projecting the global medical device outsourcing market to grow from USD 160.96 billion in 2025 to USD 494.35 billion by 2035, driven by an aging population and demand for operational efficiency. The report highlights key industry players such as WuXiAppTec, Integer Holdings Corporation, and FLEX LTD., while noting that Asia-Pacific and North America are the leading regional markets. A specific recent development noted is Integer Holdings' $220 million acquisition of Oscor Inc. to expand its manufacturing capabilities.GlobeNewswireInteger Holdings Corporation Completes Acquisition of Oscor, Inc.Integer Holdings completed its acquisition of Oscor, a medical device company specializing in cardiac pacing and neurostimulation leads. The deal expands Integer's product offering and adds low-cost manufacturing capacity in the Dominican Republic. Oscor's brand will deepen customer relationships and bring new clients.MedicaldesignandoutsourcingInteger completes $220M Oscor acquisitionInteger Holdings has completed its $220 million acquisition of Oscor, a manufacturer of specialized implantable cardiac and neurostimulation devices. The deal adds design and manufacturing operations in Florida, the Dominican Republic, and Germany to Integer's portfolio, expanding its capabilities in high-growth medical technology markets.GlobeNewswireOscor Inc. is Expanding its Oscor Caribe Manufacturing Space and CapabilitiesOscor Inc. is expanding its Oscor Caribe manufacturing facility in the Dominican Republic, adding 200,000 sq ft of cleanroom space over four years. The $10 million investment will add over 400 employees, with the plant expected to employ over 1,500 by 2024.GlobeNewswireOscor launches Breezeway II Transseptal Access Delivery SystemOscor received CE Mark, FDA, and Health Canada clearance for its Breezeway II transseptal access delivery system. The system offers sheath sizes from 6F to 14F and includes a valve bypass and device loader. It is available immediately under Oscor and OEM branding.FinSMEsMicro Interventional Devices Closes $20M Series D FinancingMicro Interventional Devices closed a $20M Series D round led by Oscor, with participation from Originate Ventures and others. The company will use the funds to complete its STTAR clinical trial on MIA's safety and efficacy. A strategic alliance grants Oscor exclusive manufacturing rights to MID's MIA devices.PR NewswireMicro Interventional Devices, Inc.™ geht strategische Allianz mit OSCOR, Inc.®, ein und schließt Series-D-Finanzierungsgrunde abMicro Interventional Devices, Inc. (MID) announced a strategic alliance with OSCOR, Inc. to jointly develop and commercialize MID's MIA minimally invasive annuloplasty technology for structural heart disease, with MID licensing OSCOR's catheter technology and OSCOR gaining exclusive manufacturing rights for the MIA implant. MID also closed a $20 million Series-D funding round led by OSCOR, with participation from Originate Ventures, LLC, LifeSciences Greenhouse, and Ben Franklin Venture Partners. The proceeds will fund completion of the STTAR clinical study evaluating the MIA implant's safety and efficacy for percutaneous treatment of tricuspid and mitral valve insufficiency, which affects an estimated 12 million people worldwide.PR NewswireMicro Interventional Devices, Inc.™ conclut une alliance stratégique avec OSCOR, Inc.® et boucle une levée de fonds de série DMicro Interventional Devices, Inc. (MID) and OSCOR, Inc. have formed a strategic alliance wherein MID acquires a global license for OSCOR's catheter technology in exchange for granting OSCOR exclusive manufacturing rights to MID's MIA devices. Concurrently, MID is closing a $20 million Series D funding round led by OSCOR to support its ongoing STTAR clinical trial for treating tricuspid and mitral regurgitation. This partnership also results in OSCOR's CEO joining MID's board of directors.